Drugs / Depot-Medroxyprogestereone Acetate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05505435 Comparator | Aug 2022 → Sep 2023 | — | Northwestern University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Depot-Medroxyprogestereone Acetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05505435 ↗ |
| Route | Intramuscular | “subcutaneous depot medroxyprogesterone acetate” NCT05505435 ↗ |
| Route | Subcutaneous | “subcutaneous depot medroxyprogesterone acetate” NCT05505435 ↗ |